Products & safety
Mycotoxins: fungal toxins, major families, food testing, processing and diagnostic uncertainty
On this page
Mycotoxins are chemicals made by particular molds, sometimes contaminating crops and foods. They form several families with different food sources, toxicities and evidence. A toxin in a grain, a moldy surface and a urine-test result are different findings that need different interpretation.[2]
A mold is an organism; a mycotoxin is a chemical
Mycotoxins are toxic compounds produced by certain fungi under suitable conditions. They are not the mold itself: finding a fungus does not identify which toxin or how much is present. Contamination can occur before harvest or during storage. Many toxins survive processing; killing mold does not automatically remove chemicals already produced. Interpretation requires toxin-specific contamination and resulting exposure.[1]
Different families have different evidence
FDA's monitoring covers several distinct toxin families rather than a universal mold-toxin test. DON is associated with grains and gastrointestinal effects at high exposure. Fumonisins often involve corn; important toxicity evidence comes from animals, with human effects less completely resolved. Patulin commonly concerns apple products, and pasteurization does not remove it. Aflatoxin M1 can enter milk when cows consume contaminated feed. These pathways require particular analytes, sample matrices and interpretation rather than a single good-or-bad food label.[2]
| Family | Common context or distinction |
|---|---|
| Aflatoxins | Grains/nuts; M1 is a milk-associated metabolite[1] |
| DON | Grains; also called vomitoxin[2] |
| Fumonisins | Often corn; several related compounds[2] |
| Patulin | Apple products; distinct from grain toxins[2] |
| Ochratoxin A | Several foods; animal kidney toxicity evidence[6] |
| T-2/HT-2 and zearalenone | Fusarium-associated grain toxins; separate analytes[3] |
A laboratory panel has an analyte and food scope
FDA’s C-003 analytical method lists twelve measured toxins and food matrices in which it was validated. Chromatography, mass spectrometry and confirmation criteria address identification; they do not include every possible toxin. Retain analyte names, concentration units, detection or quantification limits and sampling information. Non-detection outside the method’s scope says nothing about an unmeasured chemical. Detection alone does not provide a person’s intake or diagnosis.[4]
Prevention begins before the kitchen
WHO emphasizes drying and dry storage because moisture and damage encourage fungal growth. Store foods properly, buy quantities that will be used and discard visibly moldy or damaged grains and nuts. Dietary variety reduces repeated exposure from one source. Inspection helps prevention but cannot certify absence of invisible chemicals or rescue contaminated food by heating.[1]
Evidence & uncertainty
This overview distinguishes selected food-safety assessments from clinical claims. Animal studies, human exposure estimates and legal food limits answer different questions. Uncertainty about one toxin's mechanism or a diagnostic test does not erase the established need to control contamination.[6]
Selected-source overview · Independent review pendingPublished questions
Does every mold produce mycotoxins?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA explains that only certain molds produce toxins of concern. The organism, toxin and measured amount are separate findings.[2]
Evidence behind this answer
- Mycotoxins
agency guidance or assessment · 2026
Original official page and selected relevant passages inspected; no independent expert review · Families including DON, fumonisins, patulin, ochratoxin; milk transfer; processing limits
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can heating guarantee removal?
Selected-source overview · Independent review pending. Read the evidence context.
No. WHO says many mycotoxins are chemically stable and survive processing. The effect depends on the toxin, process and food.[1]
Evidence behind this answer
- Mycotoxins
agency guidance or assessment · 2023
Original official page and selected relevant passages inspected; no independent expert review · Definitions; food exposure; chemical stability; common families; household storage and diversity
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a twelve-toxin panel cover every mycotoxin?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA's method has named analytes and validated food matrices. A result cannot establish absence of chemicals outside that scope.[4]
Evidence behind this answer
- CAM C-003.03: Determination of Mycotoxins in Corn, Peanut Butter, and Wheat Flour
agency guidance or assessment · 2024
Original FDA analytical method PDF scope and principle sections inspected; entire validation dataset not independently reanalyzed · Section 2024.2 scope, twelve analytes, validated matrices; 2024.3 extraction and confirmation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are all mycotoxins equally carcinogenic?
Selected-source overview · Independent review pending. Read the evidence context.
No. EFSA's ochratoxin assessment shows distinct mechanisms and uncertainty. Hazard evidence and human exposure must be assessed for the particular toxin.[6]
Evidence behind this answer
- Risk assessment of ochratoxin A in food
agency guidance or assessment · 2020
Original agency assessment abstract and selected summary passages inspected; underlying studies not independently appraised · Abstract and summary: animal kidney toxicity, unclear genotoxic mechanism, margin of exposure
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a urine detection prove my building made me ill?
Selected-source overview · Independent review pending. Read the evidence context.
No. CDC's field report explains dietary detection and clinical-validity limits. A positive test alone cannot identify an environmental source or diagnose illness.[8]
Evidence behind this answer
- Use of Unvalidated Urine Mycotoxin Tests for Clinical Diagnosis of Illness — United States, 2014
agency guidance or assessment · 2015
Original historical CDC field report inspected; diagnostic principles cited, not a claim that all regulatory details remain unchanged · 2015 field report: dietary urinary detection, absent disease-predictive levels and clinical-validity distinction
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What does masked mycotoxin mean?
Selected-source overview · Independent review pending. Read the evidence context.
EFSA uses it for certain modified or matrix-associated forms. Some can release parent compounds during digestion, creating analytical and assessment uncertainties.[5]
Evidence behind this answer
- Risks related to modified forms of certain mycotoxins in food and feed
agency guidance or assessment · 2014
Original agency assessment abstract and bibliographic metadata inspected; underlying studies not independently appraised · Abstract: masked forms, digestion releases, assumptions of parent toxicity and data gaps
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can I compare my food with any listed limit?
Selected-source overview · Independent review pending. Read the evidence context.
No. EU limits specify toxins and food categories. Preserve those categories and the jurisdiction rather than borrowing the most convenient number.[7]
Evidence behind this answer
- Mycotoxins
agency guidance or assessment · 2024
Original official page and selected relevant passages inspected; no independent expert review · Maximum levels by toxin and food category under EU 2023/915 as amended
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
More monitored toxins does not mean more disease
FDA expanded its human-food compliance program in 2024 to include T-2/HT-2 toxins and zearalenone, alongside multi-mycotoxin analysis. This can improve information about incidence and co-occurrence. More detections after a broader or more sensitive method may reflect measurement changes as well as contamination changes. Human-food and animal-feed surveillance have distinct scopes. Monitoring does not independently establish that each detected mixture caused illness.[3]
Animal findings and human outcomes need distinction
EFSA's ochratoxin A assessment found kidney toxicity in animals and kidney tumors in rodents, with uncertainty about the mechanism of genotoxicity. It used a margin-of-exposure approach rather than establishing a health-based guidance value in that assessment. This illustrates why mycotoxin families cannot share one cancer claim or one safe-dose number. Evidence of hazardous potential supports control, but translating it into human risk requires exposure information and careful handling of animal-to-human and mechanistic uncertainty.[6]
Modified toxins complicate a simple panel
EFSA evaluated modified, sometimes called masked, forms produced through fungal or plant metabolism or association with the food matrix. Digestion can release some parent compounds. Its 2014 assessment used assumptions where specific toxicity data were missing and identified uncertainty. That supports asking what a method measures, rather than assuming a parent-only result captures every related exposure. It also does not justify treating every unmeasured derivative as present or equally hazardous in a particular product.[5]
Urinary detection is not a mold-illness diagnosis
A 2015 CDC field report warned that dietary mycotoxins can appear in healthy people’s urine; disease-predictive levels had not been established for the tests discussed. Laboratory certification and clinical validity differ. This does not deny foodborne hazards or damp-building health effects. A positive result alone cannot identify a building source or justify treatment. Persistent symptoms deserve clinical assessment.[8]
Regulatory limits retain their food category
The Finnish Food Authority describes EU maximum levels for named toxins in specified food categories. These are legal risk-management instruments, not personal daily doses. A grain standard should not be applied to milk or a feed limit to human food. Use the exact analyte, food, sampling rules and jurisdiction when comparing results; this overview does not reproduce complete amended tables.[7]
References
- Mycotoxins
Agency guidance or assessment
WHO · Content/publication date: 2023
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
Cited sections: Definitions; food exposure; chemical stability; common families; household storage and diversityPublication or content date is distinct from access date; no claim of continuous monitoring.
- Mycotoxins
Agency guidance or assessment
US FDA · Content/publication date: 2026
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
Cited sections: Families including DON, fumonisins, patulin, ochratoxin; milk transfer; processing limitsPublication or content date is distinct from access date; no claim of continuous monitoring.
- FDA Updates Mycotoxins in Domestic and Imported Human Foods Compliance Program
Agency guidance or assessment
US FDA · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
Cited sections: Expanded T-2/HT-2 and zearalenone monitoring; multi-analyte analysis and co-occurrencePublication or content date is distinct from access date; no claim of continuous monitoring.
- CAM C-003.03: Determination of Mycotoxins in Corn, Peanut Butter, and Wheat Flour
Agency guidance or assessment
US FDA / Kai Zhang · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Original FDA analytical method PDF scope and principle sections inspected; entire validation dataset not independently reanalyzed
Cited sections: Section 2024.2 scope, twelve analytes, validated matrices; 2024.3 extraction and confirmationPublication or content date is distinct from access date; no claim of continuous monitoring.
- Risks related to modified forms of certain mycotoxins in food and feed
Agency guidance or assessment
EFSA CONTAM Panel · Content/publication date: 2014
Accessed: 2026-10-13 UTC · Original agency assessment abstract and bibliographic metadata inspected; underlying studies not independently appraised
Cited sections: Abstract: masked forms, digestion releases, assumptions of parent toxicity and data gapsPublication or content date is distinct from access date; no claim of continuous monitoring.
- Risk assessment of ochratoxin A in food
Agency guidance or assessment
EFSA CONTAM Panel · Content/publication date: 2020
Accessed: 2026-10-13 UTC · Original agency assessment abstract and selected summary passages inspected; underlying studies not independently appraised
Cited sections: Abstract and summary: animal kidney toxicity, unclear genotoxic mechanism, margin of exposurePublication or content date is distinct from access date; no claim of continuous monitoring.
- Mycotoxins
Agency guidance or assessment
Finnish Food Authority · Content/publication date: 2024
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected; no independent expert review
Cited sections: Maximum levels by toxin and food category under EU 2023/915 as amendedPublication or content date is distinct from access date; no claim of continuous monitoring.
- Use of Unvalidated Urine Mycotoxin Tests for Clinical Diagnosis of Illness — United States, 2014
Agency guidance or assessment
Kawamoto M, Page E / CDC MMWR · Content/publication date: 2015
Accessed: 2026-10-13 UTC · Original historical CDC field report inspected; diagnostic principles cited, not a claim that all regulatory details remain unchanged
Cited sections: 2015 field report: dietary urinary detection, absent disease-predictive levels and clinical-validity distinctionPublication or content date is distinct from access date; no claim of continuous monitoring.
Scope & review
- Population
- General readers; vulnerable populations and source-specific exposure settings are distinguished
- Exposure or intervention
- Mycotoxins
- Comparison
- Chemical forms, exposure routes, source-specific populations and jurisdiction-specific rules
- Outcomes
- Definitions, categories, exposure interpretation, practical questions and uncertainty
- Timeframe
- Selected historical and current sources checked 2026-10-13; publication dates are recorded separately
- Jurisdiction
- US and explicitly identified international guidance; local requirements differ
Bounded selected-source educational explanation. Agency assessments and editorial interpretation are distinguished; no exhaustive search, independent systematic synthesis or qualified medical review.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added definition-first explainer with exposure distinctions, source-linked questions and uncertainty.
What this article still leaves open
- No current brand ranking, complete legal-limit table or clinical diagnostic protocol is supplied.
- Mixture effects, modified toxins and generalization from animal studies remain source-specific uncertainties.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.